Global X Aging Population... (LNGR)
| Bid | - |
| Market Cap | 39.38M |
| AUM | 40.12M |
| NAV | 28.27 |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 1.42M |
| Inception Date | May 9, 2016 |
| Ask | - |
| Volume | 2.81K |
| Open | 27.67 |
| Previous Close | 27.45 |
| Day's Range | 27.49 - 27.79 |
| 52-Week Range | 21.90 - 29.52 |
| Holdings | 99 |
| Expense Ratio | 0.50% |
About LNGR
The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Top 10 Holdings 34.77% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 4.04% |
| Amgen Inc. | AMGN | 3.84% |
| Bristol-myers Squibb... | BMY | 3.56% |
| Regeneron Pharmaceut... | REGN | 3.52% |
| Novo Nordisk A/s-b | NOVOB DC | 3.48% |
| Boston Scientific Co... | BSX | 3.35% |
| Johnson & Johnson | JNJ | 3.29% |
| Biogen Inc. | BIIB | 3.25% |
| Astrazeneca PLC | AZN | 3.24% |
| Abbvie Inc. | ABBV | 3.20% |
Dividends Dividend Yield 0.36%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2020 | $0.0550 | Jan 8, 2021 |
| Jun 29, 2020 | $0.0449 | Jul 8, 2020 |
| Dec 30, 2019 | $0.0899 | Jan 8, 2020 |
| Jun 27, 2019 | $0.0529 | Jul 8, 2019 |
| Dec 28, 2018 | $0.1279 | Jan 8, 2019 |
4 years ago · seekingalpha.com
Healthcare: A Wide Choice Of Large And Well-Established CompaniesThe advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...
5 years ago · seekingalpha.com
An ETF For Every Theme: COVID-19 Lightning Round With Global X (Podcast)The COVID-19 pandemic has created a massive divergence in performance among thematic ETFs. Among the most pioneering of the thematic ETF issuers, Global X's CEO Luis Berruga joins Let's Talk ETFs to d...
